MedPath

A clinical study to determine the effectiveness of 2% lignocaine with varying concentration of adrenaline used in dental extraction procedures.

Phase 2
Conditions
Health Condition 1: K089- Disorder of teeth and supporting structures, unspecified
Registration Number
CTRI/2022/07/044039
Lead Sponsor
Self Dr Namrata Patil
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Individuals falling in 40-60 age group.

individuals needing maxillary molar/premolar extractions.

Individuals with controlled hypertension.

Exclusion Criteria

Individuals with known H/O of thyroid disorder, renal disease , uncontrolled hypertension ,under antiplatelets & anticoagulant therapy , bronchial asthma and pregnant females

Patients with known allergy to any of the study drugs.

Mentally challenged patients.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Pain measured by Visual Analog ScaleTimepoint: 5 minutes
Secondary Outcome Measures
NameTimeMethod
Blood pressureTimepoint: Mm of Hg by automated sphygmomanometer before and after LA injection and immediately after completion of the extraction procedure.;Need for suturingTimepoint: yes/no;PulseTimepoint: Beats per minute before and after injection of local anesthetic and immediately after extraction procedure;Volume of anesthetic agentTimepoint: ml
© Copyright 2025. All Rights Reserved by MedPath